J.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)

TipRanksNov 21 20:06 · Ratings

SpringWorks Therapeutics Initiated at Outperform by Evercore ISI Group

Dow JonesNov 21 01:10 · Ratings

SpringWorks Therapeutics Analyst Ratings

BenzingaNov 21 00:58 · Ratings

Evercore Initiates SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $60

Futu NewsNov 20 21:33 · Ratings

JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking AlphaNov 20 00:06

SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark

Zacks Nov 13 22:55